The Microsponge® Delivery System (MDS): a topical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the release of actives
- 1 January 1996
- journal article
- Published by Taylor & Francis in Journal of Microencapsulation
- Vol. 13 (5) , 575-588
- https://doi.org/10.3109/02652049609026042
Abstract
The Microsponge Delivery System (MDS) is a unique technology for the controlled release of topical agents and consists of macroporous beads, typically 10-25 microns in diameter, loaded with active agent. When applied to the skin, the MDS releases its active ingredient on a time mode and also in response to other stimuli (rubbing, temperature, pH, etc). MDS technology is being used currently in cosmetics, over-the-counter (OTC) skin care, sunscreens and prescription products. By delivering the active gradually to the skin, MDS-benzoyl peroxide formulations, for example, have excellent efficacy with minimal irritation. These are typical benefits from the use of the MDS.Keywords
This publication has 4 references indexed in Scilit:
- Controlled release of benzoyl peroxide from a porous microsphere polymeric system can reduce topical irritancyJournal of the American Academy of Dermatology, 1991
- MicrospongeR Delivery Systems (MDS): A Topical Delivery System with Multiple Mechanism for Triggering the Release of ActivesPublished by Springer Nature ,1991
- Comparative Activity of Benzoyl Peroxide and HexachloropheneArchives of Dermatology, 1983
- A New Method for the Quantitative Investigation of Cutaneous Bacteria*Journal of Investigative Dermatology, 1965